2022
DOI: 10.2967/jnumed.122.264213
|View full text |Cite
|
Sign up to set email alerts
|

Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on18F-FDG PET Patterns in Clinical Alzheimer Disease

Abstract: Purpose: Comorbid Lewy body (LB) pathology is common in AD. The effect of LB co-pathology on FDG-PET patterns in AD is yet to be studied. We analysed associations of neuropathologically-assessed tau pathology, LB pathology, and substantia nigra neuron loss (SNnl) with ante-mortem FDG-PET hypometabolism in patients with a clinical AD presentation.Methods: Twenty-one patients with autopsy-confirmed AD ('pure-AD'), 24 with AD and LB co-pathology ('AD-LB'), and 7 with LB but no or low evidence of AD pathology ('pu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 51 publications
2
4
0
Order By: Relevance
“…According to our classification, 12.2% of the whole aMCI cohort and 12.5% of the ADD cohort showed a posterior-occipital FDG-PET pattern suggestive of Lewy body pathology. While these percentages are in good agreement with the proportion of clinical Alzheimer’s disease cases in the ADNI autopsy cohort who were found to have a primary pathological diagnosis of Lewy body pathology, 20 , 40 they are higher than those reported by previous neuropathological studies focusing on similar clinical Alzheimer’s disease cohorts (3–11%). 41 , 42 According to our previous imaging-pathological study, 20 several of the LB-like cases in our study may actually reflect pathologically mixed AD-LB cases for which Lewy body pathology represents an important contribution to the neurodegeneration phenotype, which may explain the relatively large size of our LB-like group.…”
Section: Discussionsupporting
confidence: 85%
See 3 more Smart Citations
“…According to our classification, 12.2% of the whole aMCI cohort and 12.5% of the ADD cohort showed a posterior-occipital FDG-PET pattern suggestive of Lewy body pathology. While these percentages are in good agreement with the proportion of clinical Alzheimer’s disease cases in the ADNI autopsy cohort who were found to have a primary pathological diagnosis of Lewy body pathology, 20 , 40 they are higher than those reported by previous neuropathological studies focusing on similar clinical Alzheimer’s disease cohorts (3–11%). 41 , 42 According to our previous imaging-pathological study, 20 several of the LB-like cases in our study may actually reflect pathologically mixed AD-LB cases for which Lewy body pathology represents an important contribution to the neurodegeneration phenotype, which may explain the relatively large size of our LB-like group.…”
Section: Discussionsupporting
confidence: 85%
“…While these percentages are in good agreement with the proportion of clinical Alzheimer’s disease cases in the ADNI autopsy cohort who were found to have a primary pathological diagnosis of Lewy body pathology, 20 , 40 they are higher than those reported by previous neuropathological studies focusing on similar clinical Alzheimer’s disease cohorts (3–11%). 41 , 42 According to our previous imaging-pathological study, 20 several of the LB-like cases in our study may actually reflect pathologically mixed AD-LB cases for which Lewy body pathology represents an important contribution to the neurodegeneration phenotype, which may explain the relatively large size of our LB-like group. Although the actual underlying pathology in the FDG-PET-defined LB-like patients in our current study remains unknown, these patients did indeed show significantly lower PET biomarker levels of Alzheimer’s disease pathology compared to patients with an AD-like FDG-PET pattern, indicating that co-pathologies may have a greater contribution to the clinical phenotype.…”
Section: Discussionsupporting
confidence: 85%
See 2 more Smart Citations
“…DLB is also neuropathologically heterogeneous and up to seven pathologies can coexist creating a diverse mix of combinations with variable clinical consequences [9 ▪▪ ]. The few “pure” LB pathology cases usually show a more typical DLB profile with higher frequency of core features such as RBD, VH and parkinsonism [10,11]. However, the vast majority of DLB cases are “mixed”, most commonly with concomitant Alzheimer's disease neuropathological changes (ADNC), followed by other co-pathologies such as TDP-43 and cerebrovascular disease (CVD), which increase in frequency with age [9 ▪▪ ,11–19].…”
Section: Challenges In Clinical Trialsmentioning
confidence: 99%